Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats
- 1 October 1999
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 44 (1-2) , 57-65
- https://doi.org/10.1016/s0162-3109(99)00121-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Human Kallikrein Gene Delivery Attenuates Hypertension, Cardiac Hypertrophy, and Renal Injury in Dahl Salt-Sensitive RatsHuman Gene Therapy, 1998
- Transient Immunosuppression with Deoxyspergualin Improves Longevity of Transgene Expression and Ability to Readminister Adenoviral Vector to the Mouse LungHuman Gene Therapy, 1997
- Endothelial Function and Bradykinin in HumansDrugs, 1997
- Cyclophosphamide Diminishes Inflammation and Prolongs Transgene Expression Following Delivery of Adenoviral Vectors to Mouse Liver and LungHuman Gene Therapy, 1996
- Systemic and Portal Vein Delivery of Human Kallikrein Gene Reduces Blood Pressure in Hypertensive RatsHuman Gene Therapy, 1996
- Sexual Dimorphism of Cardiovascular Responses to Early Blockade of Bradykinin ReceptorsHypertension, 1996
- A gene for high urinary kallikrein may protect against hypertension in Utah kindreds.Hypertension, 1989
- Bradykinin stimulates bone resorption and lysosomal-enzyme release in cultured mouse calvariaBiochemical Journal, 1984
- Urinary kallikrein in rats bred for their susceptibility and resistance to the hypertensive effect of salt. A new radioimmunoassay for its direct determination.Circulation Research, 1978
- ALTERED URINARY KALLIKREIN EXCRETION IN HUMAN HYPERTENSIONThe Lancet, 1971